Skip to main content
. Author manuscript; available in PMC: 2020 Jun 8.
Published in final edited form as: Oncology (Williston Park). 2019 Mar 13;33(3):91–100.

Table 1.

Clinical Trials Investigating Various Radiation Dosing Regimens

Author Minimum Age Fractional Dose Total Dose Duration Concurrent Chemotherapy? Median Survival
Baumann et al (1994)[83] 65 y (or KPS ≤ 50) 3.0 Gy 30.0 Gy 10 d No 6 mos
Roa et al (2004)[115] 60 y 2.67 Gy 40.0 Gy 15 d No 5.6 mos
Malmstrom et al (2012)[81] 60 y 3.4 Gy 34.0 Gy 10 d No 7.5 mos
Roa et al (2015)[84] 65 y (or KPS 50–70) 5.0 Gy 25.0 Gy 5 d No 7.9 mos
Perry et al (2017)[82] 65 y 2.67 Gy 40.0 Gy 15 d Yes 9.3 mos

KPS = Karnofsky Performance Status.